Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

Researchers explored the recovery rate and prevalence of the COVID-19-associated taste and smell impairments after two years across patients with mild symptoms.

9 Aug 2022

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

Scientists analyzed the differences between SARS-CoV-2 rebound associated with the Omicron BA.2.12.1 and BA.5 sublineages post-Paxlovid therapy in the United States.

9 Aug 2022

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Researchers demonstrated differential utilization of the B cell germlines and SARS-CoV-2 spike protein epitopes by cross-neutralizing antibodies in infected, vaccinated and individuals with hybrid immunity.

9 Aug 2022

Post-COVID-19 symptoms may occur in one of eight SARS-CoV-2-infected individuals

In a new study, researchers analyzed the nature, incidence, and severity of 23 COVID-19-related persistent symptoms in the Netherlands.

9 Aug 2022

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Scientists explored the influence of SARS-CoV-2 extended gap vaccination on the variants of concern neutralization.

9 Aug 2022

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

Researchers estimated the vaccine effectiveness (VE) of the primary and booster doses of COVID-19 vaccines against reinfection by Omicron BA.5 and BA.2 lineages and severe post-infection outcomes.

9 Aug 2022

How did perceived social support across COVID-19 restrictions alter alcohol and cannabis use in emerging adults?

Researchers demonstrated changes in alcohol and cannabis use among young adults in Canada and the United States during pre-COVID-19 times, COVID-19-induced lockdown, and when social restrictions eased later.

9 Aug 2022

Study suggests BA.5 evolved to induce enhanced inflammation when compared to prior Omicron subvariants

Researchers evaluated the comparative pathogenicity of SARS-CoV-2 Omicron sub-variants BA.1, BA.2, and BA.5, in vitro and in vivo.

9 Aug 2022

COVID-19 vaccination increases antibodies in breast milk significantly

Anti-SARS-CoV-2 antibodies in breast milk capable of neutralizing both an early pandemic SARS-CoV-2 isolate and Omicron variant.

8 Aug 2022

Sperm not affected nine months after COVID-19 mRNA vaccination

A recent study compared the effects of COVID-19 vaccines on male fertility at a median of nine months after receipt of two mRNA vaccine doses.

8 Aug 2022

Study tests equine polyclonal antibodies against SARS-CoV-2 variants

A recent study published tested equine polyclonal antibodies against SARS-CoV-2.

8 Aug 2022

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

A recent paper describes the use of aprotinin, a protease inhibitor that works across several pathways, to reduce the severity of COVID-19.

8 Aug 2022

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Researchers assessed the impact of dendrimer nanotherapy in treating severe COVID-19.

8 Aug 2022

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

Researchers presented two cases to highlight the impact of cold agglutinin syndrome on clinical presentations in COVID-19.

8 Aug 2022

Research progress on the three-dimensional interaction between virus and host genome

A recent study reviewed the current progress on 3D interactions between host and viral genomes.

8 Aug 2022

What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

In a new study, investigators examined if SARS-CoV-2 Omicron BA.2 breakthrough infection in triple vaccinated individuals boosts Omicron BA.4/BA.5 and BA.2.12.1 cross-neutralization.

8 Aug 2022

What is the vaccine effectiveness of BNT162b2 against Omicron in five to 11-year-olds?

Researchers evaluated the effectiveness of the BNT162b2 vaccine against the new SARS-CoV-2 variant of concern, Omicron, in five to 11-year-old children of Ontario, Canada.

8 Aug 2022

What were the health effects of long COVID during the SARS-CoV-2 Omicron wave?

A new study examined the health influences of long coronavirus disease during the 2021 to 2022 SARS-CoV-2 Omicron surge in Australia.

8 Aug 2022

Assessing immunization capacity of vaccine platforms with DNA origami harboring SARS-CoV-2 receptor binding domain

Researchers demonstrated that vaccine frameworks containing deoxyribonucleic acid (DNA) origami possessing SARS-CoV-2 receptor-binding domain induce strong protective immunity.

8 Aug 2022

How can we map the human genetic architecture of COVID-19 across all ancestry groups?

In a new study, researchers formed the COVID-19 host genetics initiative to compile a genome-wide association meta-analysis of 60 studies from 25 countries.

8 Aug 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Almost 90% of subjects who experience COVID-19-linked taste or smell dysfunction fully recover after two years

How does COVID-19 rebound after Paxlovid treatment differ between the BA.5 and BA.2.12.1 subvariants?

The neutralizing activity of a panel of 482 human monoclonal antibodies against Omicron BA.4 and BA.5

Post-COVID-19 symptoms may occur in one of eight SARS-CoV-2-infected individuals

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

How did perceived social support across COVID-19 restrictions alter alcohol and cannabis use in emerging adults?

Study suggests BA.5 evolved to induce enhanced inflammation when compared to prior Omicron subvariants

COVID-19 vaccination increases antibodies in breast milk significantly

Sperm not affected nine months after COVID-19 mRNA vaccination

Study tests equine polyclonal antibodies against SARS-CoV-2 variants

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

Research progress on the three-dimensional interaction between virus and host genome

What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

What is the vaccine effectiveness of BNT162b2 against Omicron in five to 11-year-olds?

What were the health effects of long COVID during the SARS-CoV-2 Omicron wave?

Assessing immunization capacity of vaccine platforms with DNA origami harboring SARS-CoV-2 receptor binding domain

How can we map the human genetic architecture of COVID-19 across all ancestry groups?

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Newsletters you may be interested in